Through our AI algorithms, domain expertise and ability to analyse complex medical data, we are giving patients hope, from diseases, such as cancer. By helping to recruit them to the most suitable clinical trials and helping trial groups meet recruitment targets, we are able to save costs and reduce time to trial completion.
Although over 70% of patients saying they would like to be offered the opportunity to be involved in a clinical trial, only 4% of patients in the UK end up being recruited to clinical trials. Two thirds of clinical trials still fail in the UK despite best efforts. We are determined to turn around this trend by improving patient access and engagement with trials to provide hope of new treatments—and even a cure—for various diseases to millions of people around the world.
Back to Home